Redeye initiates coverage of Carasent, the Norwegian holding company of the electronic medical record (EMR) developer Evimeria. This emerging compounder offers an attractive growth play on healthcare digitization with notable protection from its strong moats. Near-term catalysts include expansion to neighboring countries.
Read more and download the Research Report
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/